文献速递呼吸衰竭与机械通气心脑血管急症

基于单一问题「肺栓塞是否最可能诊断」的D-二聚体阈值诊断肺栓塞:一项前瞻性、多中心、开放标签、单臂干预研究

D-Dimer thresholds for diagnosis of pulmonary embolism based on a single question: is it the most likely diagnosis? A prospective, multicentre, open-label, single-arm interventional study.
PubMed 文献 · Lancet Respir Med · 2025-10-21
一句话结论在13个法国急诊科的前瞻性单臂研究中,对肺栓塞不是最可能诊断者用1000 ng/mL D-二聚体阈值、其他患者用年龄校正阈值,可安全排除肺栓塞并将胸部影像检查率降至32%。

该前瞻性、多中心、开放标签、单臂干预研究在13个法国医院急诊科纳入1221例临床疑诊肺栓塞的成人患者。干预为:肺栓塞不是最可能诊断且D-二聚体<1000 ng/mL者不做胸部影像即排除肺栓塞;其他患者采用年龄校正D-二聚体阈值(<50岁500 ng/mL,≥50岁年龄×10 ng/mL)。初始排除肺栓塞患者的诊断失败率(3个月随访血栓栓塞事件)为0.00%(95%CI 0.00-0.34),对33例无随访者多重插补后为0.12%(0.01-0.55),均低于1.85%安全界值。未做胸部影像即排除的796例亚组诊断失败率为0.00%(0.00-0.46)。策略胸部影像检查率为32%(384/1217),较固定500 ng/mL阈值策略的50%(609/1215)绝对降低19%(16-21)。

要点

  • 肺栓塞不是最可能诊断且D-二聚体<1000 ng/mL者可不做胸部影像排除肺栓塞,该亚组796例诊断失败率0.00%(95%CI 0.00-0.46)。
  • 其他患者采用年龄校正阈值(<50岁500 ng/mL,≥50岁年龄×10 ng/mL),全组初始排除者诊断失败率0.00%(95%CI 0.00-0.34)。
  • 该策略胸部影像检查率32%(384/1217),较固定500 ng/mL阈值策略50%(609/1215)绝对降低19%(95%CI 16-21)。
  • 安全性界值为诊断失败率双侧95%CI上限<1.85%,初始排除组及未做影像排除亚组均满足。
  • 3个月随访期间共16例死亡。

适用人群与场景

  • 13个法国医院急诊科中年龄≥18岁、临床疑诊肺栓塞的患者。
  • 排除正在接受全剂量抗凝治疗者及过去6个月内发生过血栓栓塞事件者。

诊断标准与关键阈值

  • 肺栓塞不是最可能诊断且D-二聚体<1000 ng/mL者,不做胸部影像即排除肺栓塞。
  • 其他患者采用年龄校正D-二聚体阈值:<50岁为500 ng/mL,≥50岁为年龄×10 ng/mL。
  • 安全性界值:初始排除肺栓塞患者中诊断失败率(3个月随访血栓栓塞事件)双侧95%CI上限<1.85%。

处置流程与药物剂量

  • 第一步:对临床疑诊肺栓塞者判断肺栓塞是否为最可能诊断。
  • 第二步:肺栓塞不是最可能诊断且D-二聚体<1000 ng/mL者,不做胸部影像即排除肺栓塞。
  • 第三步:其他患者按年龄校正阈值判读D-二聚体(<50岁500 ng/mL,≥50岁年龄×10 ng/mL)。

研究设计与关键结果

  • 研究类型为前瞻性、多中心、开放标签、单臂干预研究,13个法国医院急诊科参与,2024年1月16日至9月5日筛查1365例,纳入1221例,其中80例(7%)在初始检查时诊断肺栓塞。
  • 997例肺栓塞不是最可能诊断;初始排除肺栓塞者诊断失败率0.00%(95%CI 0.00-0.34),对33例无随访者多重插补后为0.12%(0.01-0.55),均在安全界值内。
  • 预设亚组796例未做胸部影像即排除肺栓塞,诊断失败率0.00%(95%CI 0.00-0.46),在安全界值内。
  • 策略胸部影像检查率32%(384/1217),较固定500 ng/mL D-二聚体阈值策略的50%(609/1215)绝对降低19%(95%CI 16-21)。
  • 3个月随访期间共16例死亡。

证据类型、等级与局限

  • 证据类型:前瞻性、多中心、开放标签、单臂干预研究。
  • 安全性界值:初始排除肺栓塞患者及未做胸部影像即排除亚组的诊断失败率双侧95%CI上限均<1.85%。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对肺栓塞不是最可能诊断者采用1000 ng/mL阈值、对其他患者采用年龄校正阈值的简化策略可安全排除肺栓塞,并可在急诊科安全减少胸部影像使用。
  • 适用人群为年龄≥18岁、临床疑诊肺栓塞、未接受全剂量抗凝且过去6个月内无血栓栓塞事件的急诊患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Validated diagnostic strategies for pulmonary embolism allow raising the D-dimer threshold to 1000 ng/mL in selected patients with a low probability of pulmonary embolism, but adherence to this strategy in routine practice remains poor. Retrospective studies suggest that these rules could be replaced by a single clinical question as to whether pulmonary embolism is the most likely diagnosis. We aimed to assess the safety of a simplified approach that applies a 1000 ng/mL threshold when pulmonary embolism is unlikely and an age-adjusted threshold otherwise, including patients at a high probability for pulmonary embolism.

METHODS: In this prospective interventional study in 13 French hospital emergency departments, patients aged ≥18 years with a clinical suspicion of pulmonary embolism, who were not on full-dose anticoagulant therapy and had not had a thromboembolic event in the past 6 months, were included. The intervention consisted of ruling out pulmonary embolism without chest imaging in patients for whom pulmonary embolism was not considered the most likely diagnosis and had a D-dimer value <1000 ng/mL. The age-adjusted D-dimer threshold (500 ng/mL if aged <50 years or age × 10 ng/mL if aged ≥50 years) was used for the other patients. The primary outcome was the diagnostic failure rate (ie, occurrence of a thromboembolic event at 3 months of follow-up) among patients for whom pulmonary embolism was initially ruled out. Safety was established if the upper bound of the two-sided 95% CI for the diagnostic failure rate was less than 1·85% in patients for whom pulmonary embolism was ruled out at initial testing and in a subgroup of patients for whom it was ruled out without chest imaging. This study is registered with ClinicalTrials.gov (NCT06190392) and is complete.

FINDINGS: Between Jan 16 and Sept 5, 2024, 1365 patients were screened for eligibility and 1221 were included, of whom 80 (7%) were diagnosed with pulmonary embolism at initial testing. Pulmonary embolism was not considered the most likely diagnosis for 997 patients. The diagnostic failure rate was 0·00% (95% CI 0·00-0·34) and was 0·12% (0·01-0·55) after multiple imputation for 33 patients with no available follow-up, both within the safety threshold. In the prespecified subgroup of 796 patients for whom pulmonary embolism was ruled out without chest imaging, the diagnostic failure rate was 0·00% (0·00-0·46), also within the safety threshold. The strategy had a 32% chest imaging rate (384 of 1217 patients), an absolute reduction of 19% (16-21) compared with the fixed 500 ng/mL D-dimer threshold strategy (609 [50%] of 1215). There were 16 deaths during the 3-month follow-up.

INTERPRETATION: A global simplified strategy using a D-dimer threshold of 1000 ng/mL in patients for whom pulmonary embolism was not the most likely diagnosis, and an age-adjusted threshold for other patients, safely excluded the diagnosis. These findings indicate that this simplified strategy could safely reduce the use of chest imaging in the emergency department.

FUNDING: Assistance Publique-Hôpitaux de Paris (Délégation à la Recherche Clinique et à l'Innovation).

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Roussel M, Bannelier H, Lebal S, et al. D-Dimer thresholds for diagnosis of pulmonary embolism based on a single question: is it the most likely diagnosis? A prospective, multicentre, open-label, single-arm interventional study. Lancet Respir Med. 2025. PMID: 41135553. doi:10.1016/S2213-2600(25)00292-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。